Table of Chemotherapy Groups

This table describes which chemotherapy drugs and treatments are in which groups. If you are taking drugs in multiple groups you should pick the most severe group, which is Group C.

For further information, please see Supplementary Box A of the BMJ paper.

Group C	Group B	Group A
All ALL/AML regimens BEP Highly immunosuppressive chemotherapy (e.g. FluDAP, high dose Methotrexate & Cytarabine) Trifuradine/ Tipracil	ABVD Anthracycline based regimens Asparaginase based regimens BEACOPP Bendamustine Brentuximab vedotin BTK inhibitors Cabazitaxel Carboplatin based regimens CHOP Chorambucil Cladrabine CMF CVAD Cyclophosphamide/Fludarabine combinations Dacarbazine based regimens Daratumumab DHAP ESHAP Etoposide based regimens FEC GDP Gemcitabine ICE Ifophosphamide based regimens IMIDs Irinotecan and Oxaliplatin based regimens JAK inhibitors Liposomal doxorubicin Lomustine Mogalizumab MVAC Nab-paclitaxel Obinutuzumab Pentostatin PI3Kinase inhibitors Proteosome inhibitors Rituximab Taxane – 3 weekly Temozolomide Topotecan Trastuzumab-emtansine Ventoclax	5FU single agent Abiraterone Anagrelide Aromatase inhibitors Atezolizumab single agent Bevacizumab single agent Bisphosphonate Busulfan Capecitabine single agent CDK4/6 inhibitors Cetuximab Cisplatin based regimens Denosumab Durvalumab Enzalutamide Fulvestrant Hydroxycarbamide Interferon (all formulations) Ipilimumab single agent Lenvatinib Methotrexate Mitomycin C mTOR inhibitors Nivolumab single agent Panitumumab PARP inhibitors Pembrolizumab single agent Pemetrexed Raltitrexed Regorafinib Sorafenib Tamoxifen Taxane – weekly Trastuzumab +/- pertuzumab Tyrosine kinase inhibitors (including ALK &/or ROS)